Oshkosh Corp (NYSE:OSK) Increases Dividend to $0.30 Per Share

Share on StockTwits

Oshkosh Corp (NYSE:OSK) declared a quarterly dividend on Wednesday, October 30th, Zacks reports. Stockholders of record on Monday, November 18th will be given a dividend of 0.30 per share on Monday, December 2nd. This represents a $1.20 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend is Friday, November 15th. This is a positive change from Oshkosh’s previous quarterly dividend of $0.27.

Shares of NYSE OSK remained flat at $$85.38 during trading hours on Friday. The company had a trading volume of 30,838 shares, compared to its average volume of 573,343. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.19 and a current ratio of 1.99. The stock has a market capitalization of $5.77 billion, a PE ratio of 10.27, a price-to-earnings-growth ratio of 0.85 and a beta of 1.97. Oshkosh has a 12 month low of $54.98 and a 12 month high of $89.80. The stock has a 50 day moving average price of $76.26 and a 200-day moving average price of $77.41.

Oshkosh (NYSE:OSK) last posted its earnings results on Wednesday, October 30th. The company reported $2.17 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.88 by $0.29. The company had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.11 billion. Oshkosh had a return on equity of 22.70% and a net margin of 7.04%. Oshkosh’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the firm earned $1.80 earnings per share. On average, equities research analysts anticipate that Oshkosh will post 7.87 earnings per share for the current fiscal year.

Several research firms recently issued reports on OSK. Longbow Research cut Oshkosh from a “buy” rating to a “neutral” rating in a research note on Thursday. They noted that the move was a valuation call. JPMorgan Chase & Co. raised Oshkosh from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $85.00 to $90.00 in a research note on Wednesday, September 11th. Dougherty & Co began coverage on Oshkosh in a research note on Wednesday, August 28th. They issued a “buy” rating and a $80.00 target price on the stock. Royal Bank of Canada raised their target price on Oshkosh to $98.00 and gave the stock an “outperform” rating in a research note on Thursday. Finally, ValuEngine cut Oshkosh from a “sell” rating to a “strong sell” rating in a research report on Wednesday, October 2nd. Four research analysts have rated the stock with a sell rating, two have assigned a hold rating and nine have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $86.27.

About Oshkosh

Oshkosh Corporation designs, manufactures, and markets specialty vehicles and vehicle bodies worldwide. The company's Access Equipment segment provides aerial work platforms and telehandlers for use in various construction, industrial, institutional, and general maintenance applications. This segment also offers rental fleet loans and leases, and floor plan and retail financing through third-party funding arrangements; towing and recovery equipment; carriers and wreckers; equipment installation services; and chassis and service parts sales.

Recommended Story: What are the disadvantages of after-hours trading?

Dividend History for Oshkosh (NYSE:OSK)

Receive News & Ratings for Oshkosh Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oshkosh and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Global Currency Reserve  Price Hits $0.0266 on Exchanges
Global Currency Reserve Price Hits $0.0266 on Exchanges
NexTier Oilfield Solutions  and The Competition Critical Analysis
NexTier Oilfield Solutions and The Competition Critical Analysis
Bitsdaq  Price Tops $0.0010 on Exchanges
Bitsdaq Price Tops $0.0010 on Exchanges
Genesis Healthcare  Announces  Earnings Results
Genesis Healthcare Announces Earnings Results
Concert Pharmaceuticals  Announces Quarterly  Earnings Results, Beats Expectations By $0.13 EPS
Concert Pharmaceuticals Announces Quarterly Earnings Results, Beats Expectations By $0.13 EPS
XcelToken Plus  Price Hits $0.0006 on Major Exchanges
XcelToken Plus Price Hits $0.0006 on Major Exchanges


© 2006-2019 Ticker Report